-
1
-
-
0016630250
-
Clofibrate and niacin in coronary heart disease
-
Clofibrate and niacin in coronary heart disease. JAMA. 1231:1975;360-381.
-
(1975)
JAMA
, vol.1231
, pp. 360-381
-
-
-
2
-
-
0023001772
-
Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
-
Canner PL, Berge KG, Wenger NK, Stamier J, Friedman L, Prineas RJ, Friedewaid W. Fifteen year mortality in Coronary Drug Project patients long-term benefit with niacin . J Am Coll Cardiol. 8:1986;1245-1255.
-
(1986)
J Am Coll Cardiol
, vol.8
, pp. 1245-1255
-
-
Canner, P.L.1
Berge, K.G.2
Wenger, N.K.3
Stamier, J.4
Friedman, L.5
Prineas, R.J.6
Friedewaid, W.7
-
3
-
-
0023910325
-
Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid
-
Carlson LA, Rosenhamer G. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand. 223:1988;405-418.
-
(1988)
Acta Med Scand
, vol.223
, pp. 405-418
-
-
Carlson, L.A.1
Rosenhamer, G.2
-
4
-
-
0025086998
-
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia
-
Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD Jr. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med. 323:1990;946-955.
-
(1990)
Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med
, vol.323
, pp. 946-955
-
-
Buchwald, H.1
Varco, R.L.2
Matts, J.P.3
Long, J.M.4
Fitch, L.L.5
Campbell, G.S.6
Pearce, M.B.7
Yellin, A.E.8
Edmiston, W.A.9
Smink R.D., Jr.10
-
5
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) . Lancet. 1344:1994;1383-1389.
-
(1994)
Lancet
, vol.1344
, pp. 1383-1389
-
-
-
6
-
-
0029032134
-
Preventing heart attack and death in patients with coronary disease
-
Smith SC Jr, Blair SN, Criqui MH, Fletcher GF, Fuster V, Gersh BJ, Gotto AM, Gould KL, Greenland P, Grundy SM. Preventing heart attack and death in patients with coronary disease. Circulation. 92:1995;2-4.
-
(1995)
Circulation
, vol.92
, pp. 2-4
-
-
Smith S.C., Jr.1
Blair, S.N.2
Criqui, M.H.3
Fletcher, G.F.4
Fuster, V.5
Gersh, B.J.6
Gotto, A.M.7
Gould, K.L.8
Greenland, P.9
Grundy, S.M.10
-
7
-
-
0029004377
-
Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
-
Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet. 1345:1995;1274-1275.
-
(1995)
Lancet
, vol.1345
, pp. 1274-1275
-
-
-
8
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
-
Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 335:1996;1001-1009.
-
(1996)
Cholesterol and Recurrent Events Trial Investigators. N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
Rouleau, J.L.4
Rutherford, J.D.5
Cole, T.G.6
Brown, L.7
Warnica, J.W.8
Arnold, J.M.9
Wun, C.C.10
Davis, B.R.11
Braunwald, E.12
-
9
-
-
0030298224
-
ACC/AHA guidelines for the management of patients with acute myocardial infarction
-
Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE Jr, Weaver WD. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 128:1996;1328-1428.
-
(1996)
A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol
, vol.128
, pp. 1328-1428
-
-
Ryan, T.J.1
Anderson, J.L.2
Antman, E.M.3
Braniff, B.A.4
Brooks, N.H.5
Califf, R.M.6
Hillis, L.D.7
Hiratzka, L.F.8
Rapaport, E.9
Riegel, B.J.10
Russell, R.O.11
Smith E.E., Jr.12
Weaver, W.D.13
-
10
-
-
0031030620
-
The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts
-
The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. The Post Coronary Artery Bypass Graft Trial Investigators. N Engl J Med. 336:1997;153-162.
-
(1997)
The Post Coronary Artery Bypass Graft Trial Investigators. N Engl J Med
, vol.336
, pp. 153-162
-
-
-
11
-
-
0028154543
-
Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
-
Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 89:1994;1329-1345.
-
(1994)
Circulation
, vol.89
, pp. 1329-1345
-
-
-
12
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
-
Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 333:1995;1301-1307.
-
(1995)
West of Scotland Coronary Prevention Study Group. N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
Isles, C.G.4
Lorimer, A.R.5
MacFarlane, P.W.6
McKillop, J.H.7
Packard, C.J.8
-
13
-
-
0028020982
-
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events
-
Furberg CD, Adams HP Jr, Applegate WB, Byington RP, Espeland MA, Hartwell T, Hunninghake DB, Lefkowitz DS, Probstfield J, Riley WA. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation. 190:1994;1679-1687.
-
(1994)
Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation
, vol.190
, pp. 1679-1687
-
-
Furberg, C.D.1
Adams H.P., Jr.2
Applegate, W.B.3
Byington, R.P.4
Espeland, M.A.5
Hartwell, T.6
Hunninghake, D.B.7
Lefkowitz, D.S.8
Probstfield, J.9
Riley, W.A.10
|